Outstanding Poster Presentation Awards

About the Award

The top poster presentations from each of the three poster sessions that occur during the ASGCT Annual Meeting are awarded Outstanding Poster Presentation Awards. Awardees are honored through notification to all meeting attendees and receive a special certificate for their contributions 

Criteria and Selection

Any ASGCT member or associate member who submits an abstract to the Annual Meeting is eligible to receive the award. For more information, review the abstract submission guidelines coming soon.

Past Recipients


Juan Aponte-Ubillus
Bioprocess Strategies to Mitigate the Impact of Proteases on Adeno-Associated Viral (AAV) Vector VP1 Capsid Content

Motahareh Arjomandnejad
Tropism of AAV-rh32.33 for Skin Endothelial Cells and Fibroblasts

Matthew Burke
Comprehensive Evaluation of the Fiber Type and Fiber Size Preference of AAV8 and AAV9 in the Canine DMD Model

Jacob Bridge
Efficient Non-Viral Engineering and Large-Scale Expansion of Polyclonal γδ T Cells

Dylan Cable
Cell Type-Specific Differential Expression in Spatial Transcriptomics for Identification of Pathologically-Relevant Genetic Targets

Hao Chang
Tri-GalNAc Conjugation to AAV Capsid Enhances Transduction of Human Hepatocytes In Vitro

Kristina Chern
Evaluation of rAAV Serotypes in the Murine Anterior Chamber for the Treatment of Glaucoma

Miguel Chuapoco
Intravenous Gene Transfer Throughout the Brain of Infant Old World Primates Using AAV

Cristina Colleoni
Characterization of the Non-Cell Autonomous Effects of Oncogene Activation on Hematopoiesis as a Possible Adverse Event in HSC Gene Therapy

Colin Cook
AAV Superproduction: Achieving 1016vg/L Productivity in the High Density Cell Respirator

Jérôme Denard
AAV-Mediated Gene Therapy of Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME) and Farber Disease

Zac Elmore
AAV Hijacks Cellular Secretion Machinery for Efficient Viral Egress

Ryan Fink
Novel RNA Therapeutic Strategy to Optimize RNA Targeting in Brain Cancer

Anna Hartley
Identification of an Antiviral Drug as a Novel Potentiator of H-1PV-Mediated Oncolysis

Juliette Hordeaux
Determining the Minimum Effective Dose (MED) of a Clinical Candidate AAV Vector Encoding Engineered Alpha-Galactosidase A Transgene in a Mouse Model of Fabry Disease

Ram Jha
Development of a Minocycline Mediated Protein-Protein Displacement Platform Using an Anti-Minocycline Single Domain Antibody and a Dedicated Displaceable Peptide

Seonah Kang
Adaptation of Multi-Plasmid Transfection-Based AAV Production to High Density Cell Respirator Bioreactors Yields Functional Vector

Erin Kavanaugh
Nanoparticles for Correction of a Rare Cystic Fibrosis Variant

Takashi Kishimoto
Combination of ImmTOR Tolerogenic Nanoparticles and IL-2 Mutein Synergistically Inhibits the Formation of Anti-AAV Antibodies

Myungeun Lee
A Novel Chimeric Nanosystem for Piggyback Delivery of mRNA Vectors

Anoushka Lotun
Ubiquitous ASPA Gene Therapy Changes Neuronal Cell Expression in Region-Specific Manner in Canavan Disease

Christopher Luthers
Quantification of DNA Contamination within Recombinant Adeno Associated Virus Preps Correlates with CD34+ Cell Potential

Oriana Mandolfo
Developing an iPSC-Based Therapeutic Approach to Reverse MPS IIIA Neurodegeneration

Sean McCutcheon
CRISPR-Based Epigenome Editing Screens in Primary Human T Cells

Christopher Nicolai
VivoVec: A Novel Lentiviral-Based In Vivo CAR T Cell Generation Platform with Viral Particle Surface Engineering Incorporating T Cell Activating and Co-Stimulatory Ligands

Julia Peterson
A Protocol for Expanding Mouse HSPCs to High Cell Yields for Pre-Clinical Screenings of Gene Therapy Vector Constructs

Francesco Puzzo
R-Loops as Determinant of AAV Integration by Homologous Recombination

Ziqing Qian
Development of Endosomal Escape Vehicles to Enhance the Intracellular Delivery of Oligonucleotides

Matthew Roach
Identification and Validation of Target Receptors for AAV9

Joan Roag-Soriano
AAV-Mediated Expression of αKlotho Isoforms Rescues Relevant Aging Hallmarks in SAMP8 Mice

Anna Sternberg
An Enhanced Hemostatic Factor VIII Variant for Hemophilia A Gene Therapy

Amber Van Laar
Safety and Preliminary Clinical Findings of Neurosurgical AAV2-GDNF Delivery for Parkinson’s Disease

Anne Vonada
Correction of Phenylketonuria by Drug-Mediated Expansion of Transplanted Hepatocytes In Vivo

Jennifer Waldo
Split dCas9 AAV for Knockdown of HTT

Carlos Munoz Zuluga
Identification of the Therapeutically Beneficial Intravenous Dose of AAVrh.10hFXN to Treat the Cardiac Manifestations of Friederichs's Ataxia


Marco Alessandrini
Development of Anti-CD19 Chimeric Antigen Receptor T-Cells with Immune Checkpoint Silencing

Robyn Bell
Assessment of F/HN Pseudotyped Lentiviral Vector Following Intravenous Delivery to Mice

Máté Borsos
Simultaneous Detection of AAV Genome, Transcript, and Protein Localization in Intact Cells and Tissues at High Resolution

Qian Chen
AAV9 Capsid-Anti-AAV9 Antibody Immune Complexes Promote Complement Activation and Cytokine Release In Vitro

Beatrice Cianciotti
LAG-3, Tim-3 or 2B4 Disruption Differentially Regulate the Anti-Tumor Response of TCR Gene-Edited Human Memory Stem T Cells

Agnieszka Czechowicz
Gene Therapy for Fanconi Anemia [Group A]: Preliminary Results of Ongoing RP-L102 Clinical Trials

Brianna Davey
Anti-CAR Antibody Detected after Infusion of Autologous CD4-MBL-CAR/CXCR5 CAR T Cells in SIV-Infected Rhesus Macaques

Michael Florea
High Efficiency Purification of Multiple AAV Serotypes Using AAVX Column Chromatography

Courtney Garrett
Treatment of Feline GM1 Gangliosidosis by Cerebrospinal Fluid Delivery of AAV9 or AAVrh10

Daniel Gibbs
Novel RNA-Targeting Gene Therapy Approach for Usher’s Syndrome Type II Retinitis Pigmentosa

Veronica Gough
Adenine Base Editing to Modulate mRNA Splicing as a Therapeutic Strategy for Duchenne Muscular Dystrophy

Firas Hamdan
Synergestic Tumor-Killing Effect by Cross-Hybrid IgGA Fc

Jenna Harris
Enabling Targeted Cargo Delivery to Hematopoietic Stem and Progenitor Cells with Biomimetic Nanoparticles

Dane Hazelbaker
Rigorous Assessment of Off-Target Editing by CRISPR/Cas9 in VOR33, an Engineered Hematopoietic Stem Cell Transplant for the Treatment of Acute Myeloid Leukemia

Claudia Juarez-Molina
Gene Therapy for Autoimmune Pulmonary Alveolar Proteinosis

Sushrut Kamerkar
Engineered Exosomes Efficiently Deliver STAT6 Antisense Oligonucleotides to Tumor Associated Macrophages (TAMs) Resulting in Potent Local and Systemic Anti-Tumor Activity

Jeong-A Lim
AAV-Mediated Gene Therapy Using a Novel Dual Promoter Prevents Pullulanase-Induced Cytotoxic T Lymphocyte Response and Corrects Major Affected Tissues in GSD IIIa Mice

Anne Maguire
Intravenous AAV Gene Therapy Improves Pre- and Post-Mortem Outcomes in a Feline Model of Sandhoff Disease

Ana Moreno
Long-Lasting Analgesia via Targeted In Situ Repression of Nav1.7

Christopher Nguyen
Expression of AAV Rep78 and Rep52 from Distal Baculovirus loci for Production of Gene Therapy Vectors: Proof-of-Concept and Initial Optimization

Jennifer Noel
Rod-Derived Cone Viability Factor Provides Trophic Support for Cone Photoreceptors in a Pig Model of Retinitis Pigmentosa

Yijia Pan
Temporal Gene Regulation of T Cell Enhancers by Locus Targeted Engineering Enables Cytokine Autonomy and Augments Anti-Tumor Efficacy of iPSC Derived Off-the-Shelf CAR-T Therapy

Angela Papalamprou
Directing Stepwise iPSC MSC Differentiation into iTenocytes Using Combined Transcription Factor Overexpression and Cyclic Loading in 2D Bioreactor

Adrian Pickar-Oliver
Development of AAV-Based CRISPR/Cas9 Therapies for Correcting Duchenne Muscular Dystrophy by Targeted Genomic Integration

Françoise Piguet
Intravenous Gene Therapy Apporach for Metachromatic Leukodystrophy

Maximillian Richter
P-BCMA-ALLO1 — A Fully Allogeneic Stem Cell Memory T Cell (T<sub>SCM</sub>) CAR-T Therapy Targeting BCMA for the Treatment of Multiple Myeloma Shows Potent Anti-Tumor Activity

Federico Rossari
Tumor Macrophage-Mediated Cytokine Gene Delivery Improves Trafficking and Anti-Tumor Activity of CAR T Cells against Glioblastoma

Krystal Sandza
Ultra-Sensitive AAV Capsid Detection by Immunocapture-Based Quantitative Polymerase Chain Reaction Following Factor VIII Gene Transfer

Pauline Schmit
High Throughput Phenotype-to-Phylogeny Mapping Identifies AAV Capsid Residues Involved in Neutralization by Human Sera

Nina Timberlake
Anti-c-kit CAR-T Cells Afford Effective Eradication of Human AML and Normal Hematopoietic Cells in a Preclinical Model of Safer Non-Genotoxic Stem Cell Transplant Conditioning

Jennifer Waldo
Use of a Split AAV Delivery Platform for the Evaluation of dxCas9 for Allele-Specific Silencing in Huntington’s Disease

Eric Walton
A CRISPRa Screen Identifies Transcription Factors That Can Silence or Activate rAAV Genomes

Adrian Westhaus
AAV Capsid Development in Primary Human Retinal Explants


26th Annual Meeting

May 16-20 | Los Angeles, CA

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.